With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
This media is aimed to propel the “social” mission of MSKCC, an institution suffering some seriously bad press in 2018, with an announcement on Friday that it would ban its employees from serving on corporate boards of drug and health care companies. | Thomas & Ornstein, New York Times